Cargando…
Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers
BACKGROUND: Diagnosing and treating patients with multiple primary lung cancers (MPLCs) bring challenges to the clinic, and the preliminary evidence has revealed unsatisfying outcomes after targeted therapy and immunotherapy. Therefore, we surveyed genomic profiles of MPLCs and their possible associ...
Autores principales: | Hu, Chunhong, Zhao, Lishu, Liu, Wenliang, Fan, Songqing, Liu, Junqi, Liu, Yuxuan, Liu, Xiaohan, Shu, Long, Liu, Xianling, Liu, Ping, Deng, Chao, Qiu, Zhenhua, Chen, Chen, Jiang, Yi, Liang, Qingchun, Yang, Lingling, Shao, Yang, He, Qiongzhi, Yu, Danlei, Zeng, Yue, Li, Yizheng, Pan, Yue, Zhang, Sujuan, Shi, Shenghao, Peng, Yurong, Wu, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663088/ https://www.ncbi.nlm.nih.gov/pubmed/34887263 http://dx.doi.org/10.1136/jitc-2021-003773 |
Ejemplares similares
-
A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection
por: Hu, Chunhong, et al.
Publicado: (2022) -
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer
por: Pan, Yue, et al.
Publicado: (2022) -
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
por: Hu, Chunhong, et al.
Publicado: (2021) -
Acquired Concurrent EGFR T790M and Driver Gene Resistance From EGFR-TKIs Hampered Osimertinib Efficacy in Advanced Lung Adenocarcinoma: Case Reports
por: Zeng, Yue, et al.
Publicado: (2022) -
Biological Pathway-Derived TMB Robustly Predicts the Outcome of Immune Checkpoint Blockade Therapy
por: Miao, Ya-Ru, et al.
Publicado: (2022)